JP2023517754A5 - - Google Patents
Info
- Publication number
- JP2023517754A5 JP2023517754A5 JP2022555992A JP2022555992A JP2023517754A5 JP 2023517754 A5 JP2023517754 A5 JP 2023517754A5 JP 2022555992 A JP2022555992 A JP 2022555992A JP 2022555992 A JP2022555992 A JP 2022555992A JP 2023517754 A5 JP2023517754 A5 JP 2023517754A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- chain variable
- variable region
- indicated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062991077P | 2020-03-18 | 2020-03-18 | |
| US62/991,077 | 2020-03-18 | ||
| PCT/IL2021/050269 WO2021186427A1 (en) | 2020-03-18 | 2021-03-11 | Anti- muc1-sea antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023517754A JP2023517754A (ja) | 2023-04-26 |
| JP2023517754A5 true JP2023517754A5 (enExample) | 2024-03-18 |
| JP7828286B2 JP7828286B2 (ja) | 2026-03-11 |
Family
ID=75439163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555992A Active JP7828286B2 (ja) | 2020-03-18 | 2021-03-11 | 抗ｍｕｃ１－ｓｅａ抗体 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20230085269A1 (enExample) |
| EP (1) | EP4087879B1 (enExample) |
| JP (1) | JP7828286B2 (enExample) |
| KR (1) | KR20220161267A (enExample) |
| CN (1) | CN115667312A (enExample) |
| AU (1) | AU2021239078A1 (enExample) |
| BR (1) | BR112022018629A2 (enExample) |
| CA (1) | CA3171531A1 (enExample) |
| CL (1) | CL2022002520A1 (enExample) |
| CO (1) | CO2022014726A2 (enExample) |
| CR (1) | CR20220523A (enExample) |
| CU (1) | CU20220055A7 (enExample) |
| DK (1) | DK4087879T3 (enExample) |
| DO (1) | DOP2022000193A (enExample) |
| EC (1) | ECSP22080687A (enExample) |
| FI (1) | FI4087879T3 (enExample) |
| IL (1) | IL296572A (enExample) |
| LT (1) | LT4087879T (enExample) |
| MX (1) | MX2022011553A (enExample) |
| PE (1) | PE20230602A1 (enExample) |
| PH (1) | PH12022552445A1 (enExample) |
| WO (1) | WO2021186427A1 (enExample) |
| ZA (1) | ZA202211303B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4676975A1 (en) * | 2023-03-03 | 2026-01-14 | Beone Medicines I GmbH | Muc1 and cd16a antibodies and methods of use |
| TW202436357A (zh) * | 2023-03-03 | 2024-09-16 | 瑞士商百濟神州瑞士有限責任公司 | Ｍｕｃ１抗體及使用方法 |
| AU2024318998A1 (en) | 2023-07-31 | 2026-01-22 | Sun Pharma Advanced Research Company Limited | Humanized muc1 antibody and antibody drug conjugate |
| WO2026078593A1 (en) | 2024-10-08 | 2026-04-16 | Sun Pharma Advanced Research Company Limited | Sting agonists and antibody drug conjugates thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| EP1848804B1 (en) * | 2005-01-28 | 2011-10-05 | Ramot at Tel Aviv University, Ltd. | Anti-muc1 alpha beta antibodies |
| JP5812418B2 (ja) * | 2009-04-17 | 2015-11-11 | イムナス・ファーマ株式会社 | Ａβオリゴマーに特異的に結合する抗体およびその利用 |
| ES2823351T3 (es) * | 2013-12-19 | 2021-05-06 | Arocell Ab | Anticuerpos anti-TK1 monoclonales |
| RU2746413C1 (ru) * | 2017-03-21 | 2021-04-13 | Пептрон, Инк. | Антитело, специфически связывающееся с muc1, и его применение |
| WO2018174544A2 (ko) | 2017-03-21 | 2018-09-27 | 주식회사 펩트론 | Muc1에 특이적으로 결합하는 항체 및 그의 용도 |
| US11970542B2 (en) | 2017-11-08 | 2024-04-30 | Fred Hutchinson Cancer Center | Bispecific antibodies specific for treating hematological malignancies |
-
2021
- 2021-03-11 AU AU2021239078A patent/AU2021239078A1/en active Pending
- 2021-03-11 MX MX2022011553A patent/MX2022011553A/es unknown
- 2021-03-11 IL IL296572A patent/IL296572A/en unknown
- 2021-03-11 KR KR1020227028562A patent/KR20220161267A/ko active Pending
- 2021-03-11 BR BR112022018629A patent/BR112022018629A2/pt unknown
- 2021-03-11 FI FIEP21717562.9T patent/FI4087879T3/fi active
- 2021-03-11 PE PE2022001975A patent/PE20230602A1/es unknown
- 2021-03-11 CU CU2022000055A patent/CU20220055A7/es unknown
- 2021-03-11 CR CR20220523A patent/CR20220523A/es unknown
- 2021-03-11 EP EP21717562.9A patent/EP4087879B1/en active Active
- 2021-03-11 US US17/800,345 patent/US20230085269A1/en active Pending
- 2021-03-11 JP JP2022555992A patent/JP7828286B2/ja active Active
- 2021-03-11 DK DK21717562.9T patent/DK4087879T3/da active
- 2021-03-11 PH PH1/2022/552445A patent/PH12022552445A1/en unknown
- 2021-03-11 CA CA3171531A patent/CA3171531A1/en active Pending
- 2021-03-11 CN CN202180021191.8A patent/CN115667312A/zh active Pending
- 2021-03-11 LT LTEPPCT/IL2021/050269T patent/LT4087879T/lt unknown
- 2021-03-11 WO PCT/IL2021/050269 patent/WO2021186427A1/en not_active Ceased
-
2022
- 2022-09-15 CL CL2022002520A patent/CL2022002520A1/es unknown
- 2022-09-16 DO DO2022000193A patent/DOP2022000193A/es unknown
- 2022-10-14 ZA ZA2022/11303A patent/ZA202211303B/en unknown
- 2022-10-17 EC ECSENADI202280687A patent/ECSP22080687A/es unknown
- 2022-10-18 CO CONC2022/0014726A patent/CO2022014726A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102041832B1 (ko) | 췌장암의 치료 및/또는 예방용 의약 조성물 | |
| JP2023540526A5 (enExample) | ||
| JP2021516973A5 (enExample) | ||
| JP2022514179A5 (enExample) | ||
| CN110536903A (zh) | 抗ox40抗体及其用途 | |
| CN109925511A (zh) | 用于癌的治疗和/或预防的药物 | |
| CN108690136B (zh) | 一种人源化抗tpbg抗体及其制备方法、其偶联物和应用 | |
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| JP2020522280A5 (enExample) | ||
| JP2024541680A5 (enExample) | ||
| JP2024016024A5 (enExample) | ||
| JP2020522281A5 (enExample) | ||
| EP3092252B1 (en) | Antibody targeting cell surface deposited complement protein c3d and use thereof | |
| JP2022553922A5 (enExample) | ||
| JP2022528721A5 (enExample) | ||
| JP2024540148A5 (enExample) | ||
| JP2023518153A5 (enExample) | ||
| CN111712521A (zh) | Cd38蛋白抗体及其应用 | |
| JP2023510429A5 (enExample) | ||
| JP2023549316A5 (enExample) | ||
| JP2022517216A5 (enExample) | ||
| JP2020531003A5 (enExample) | ||
| JP2023517754A (ja) | 抗ｍｕｃ１－ｓｅａ抗体 | |
| JPWO2022114163A5 (enExample) | ||
| CN112805297B (zh) | 抗人类pd-l1抗体及其用途 |